Evidence map›Paper›PMID 40418248›Full record

ReviewRheumatology international2025

Underestimated pyridoxine consumption and neurotoxicity: a novel manifestation with rheumatologic relevance - a case-based review.

Iga Kościńska-Shukla, Marta Jaskólska, Kinga Grochowalska, Marcin Okrój, Michał Chmielewski

Abstract readCase ReportsReview
In one paragraph

Review in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Iga Kościńska-ShuklaDepartment of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland. iga.koscinska@gumed.edu.pl.ORCID http://orcid.org/0000-0001-7821-0671
Marta JaskólskaDepartment of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland.ORCID http://orcid.org/0000-0002-1408-4490
Kinga GrochowalskaDepartment of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland.ORCID http://orcid.org/0000-0002-6704-1873
Marcin OkrójDepartment of Cell Biology and Immunology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland.ORCID http://orcid.org/0000-0003-2935-2301
Michał ChmielewskiDepartment of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland.ORCID http://orcid.org/0000-0001-8126-8786

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of vitamin B complex has long been studied and utilized in clinical practice, both for healthy and diseased individuals. Its beneficial effects on physical and mental performance have been proven by multiple studies leading to widespread supplementation among the general population. As of today's knowledge, vitamin B6 (pyridoxine) in excessive doses may lead to symptoms of neuropathy. Unfortunately, many of those supplementing vitamin B complex are unaware of such a risk. This case-based review presents three patients who initially searched for help due to neuropathic symptoms with the rheumatological diagnostic process following. All of them had a history of excessive vitamin B6 consumption, though through different sources. Cessation of supplementation led to prompt improvement in symptoms. These cases stress the importance of in-depth history taking and specifying instructions regarding prescribed supplements. The novelty of this article lies in the description of a patient who reported symptoms associated with central nervous system with concomitant abnormalities of the complement system, all of which resolved spontaneously upon normalization of pyridoxine concentration.

Indexed as

Dietary SupplementsNeurotoxicity SyndromesPyridoxineVitamin B ComplexAdultFemaleHumansMaleMiddle AgedPyridoxineVitamin B ComplexCentral nervous systemPeripheral nervous system diseasesPyridoxinePyridoxine/toxicityVitamin B6

Identifiers

PMID40418248
PMCPMC12106547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.